C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
RIO
-0.3300
The Fort Worth Press - C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
USD
-
AED 3.672502
AFN 64.999801
ALL 81.123148
AMD 360.500471
ANG 1.789785
AOA 917.000256
ARS 1545.2224
AUD 1.432593
AWG 1.8
AZN 1.699323
BAM 1.744435
BBD 2.013263
BDT 124.343874
BGN 1.747831
BHD 0.37725
BIF 3004
BMD 1
BND 1.278581
BOB 12.140484
BRL 5.482997
BSD 0.999585
BTN 94.811201
BWP 13.808328
BYN 2.953267
BYR 19600
BZD 2.01032
CAD 1.395745
CDF 2309.99985
CHF 0.819297
CLF 0.024881
CLP 979.229915
CNY 6.648303
CNH 6.67311
COP 3211.19
CRC 454.527211
CUC 1
CUP 23.989333
CVE 98.874952
CZK 21.7741
DJF 177.719832
DKK 6.68478
DOP 60.250267
DZD 136.047703
EGP 55.341795
ERN 15
ETB 162.433359
EUR 0.89441
FJD 2.24675
FKP 0.745229
GBP 0.745525
GEL 2.594972
GGP 0.745229
GHS 11.649649
GIP 0.745229
GMD 73.500741
GNF 8800.000044
GTQ 7.642051
GYD 209.539525
HKD 7.845775
HNL 26.869372
HRK 6.76901
HTG 131.015506
HUF 326.079501
IDR 18136.55
ILS 3.161404
IMP 0.745229
INR 94.73755
IQD 1515.298819
IRR 1879654.000336
ISK 121.830148
JEP 0.745229
JMD 158.843703
JOD 0.709046
JPY 158.244498
KES 129.939703
KGS 87.449904
KHR 4085.000211
KMF 439.999912
KPW 899.999961
KRW 1345.590138
KWD 0.31144
KYD 0.832995
KZT 452.368741
LAK 22530.000318
LBP 89550.000227
LKR 332.306128
LRD 170.225022
LSL 16.636267
LTL 2.95274
LVL 0.60489
LYD 6.414756
MAD 9.828437
MDL 18.057593
MGA 4514.054577
MKD 55.025816
MMK 2099.543828
MNT 3601.136904
MOP 8.078026
MRU 40.503405
MUR 47.296346
MVR 15.460069
MWK 1736.999996
MXN 18.60742
MYR 4.077023
MZN 63.858728
NAD 16.636267
NGN 1344.610252
NIO 36.783168
NOK 9.224075
NPR 151.697565
NZD 1.77751
OMR 0.384497
PAB 0.999799
PEN 3.467019
PGK 4.482837
PHP 63.508022
PKR 276.504083
PLN 3.95665
PYG 5917.059487
QAR 3.653878
RON 4.778806
RSD 105.237022
RUB 81.526084
RWF 1478.412502
SAR 3.764439
SBD 8.058206
SCR 13.716903
SDG 601.505751
SEK 9.795495
SGD 1.28118
SHP 0.748335
SLE 22.899227
SLL 20969.504398
SOS 571.280766
SRD 37.5795
STD 20697.981008
STN 21.85227
SVC 8.746259
SYP 13001.999685
SZL 16.630915
THB 33.779783
TJS 9.191303
TMT 3.5
TND 2.987517
TOP 2.40776
TRY 49.986598
TTD 6.761717
TWD 32.797203
TZS 2643.297997
UAH 45.650373
UGX 4277.693292
UYU 40.190338
UZS 11944.718217
VES 887.4798
VND 25766
VUV 118.901474
WST 2.774695
XAF 586.694254
XAG 0.02045
XAU 0.000256334342
XCD 2.70255
XCG 1.80143
XDR 0.707052
XOF 586.694254
XPF 106.371498
YER 236.198647
ZAR 16.66562
ZMK 9001.208965
ZMW 20.242167
ZWL 321.999592
SSP 5745.200537
MXV 2.095014
- Petrol and diesel prices remain broadly steady across major Indian cities
- India proposes more import entry points for drugs and medical devices
- Reliance shares remain in focus after near-12% surge
- Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
- 2026 Arizona Midterms: Key Races, Ballot Measures, and Voter Deadlines
- NBC’s Steve Kornacki Reveals Tech Habits Ahead of Midterm Elections
- Coal India prepares possible $1 billion Mahanadi Coalfields listing
- India and Israel oppose UN draft on regional conventional arms control
- Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination
- BLS Polymers shares open 65.3% above IPO price
C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.
Founded in 2019 by industry experts, C2Dx was built on the belief that proven medical devices still have untapped potential to serve patients and providers. Now, as Everis, the company embraces a name that evokes endurance (ever), progress (evolving), and energy (life force)-capturing the spirit of continuous innovation and purpose-driven growth.
"Everis represents who we are becoming," said Sarah Hollingsworth, Vice President of Marketing. "We're not only preserving the legacy of essential technologies-we're building their future. Our new identity reflects our mission to redefine what's possible in patient care."
While the name is new, the company's dedication remains unchanged: providing exceptional customer support, trusted solutions, and a relentless focus on enhancing outcomes.
"Our evolution into Everis reflects more than a name change-it's a signal of our long-term growth trajectory," said Kevin McLeod, CEO. "We're actively building a portfolio of transformative technologies, and we see corporate development as a vital path to scale our impact. Whether through strategic partnerships or acquisitions, we're focused on expansion and growth."
Everis will debut its new branding at COSM 2025, inviting physicians to experience what's next.
For more information, visit everismedical.com.
Media Contact:
Sarah Hollingsworth
Vice President of Marketing
Everis Medical
[email protected]
everismedical.com
SOURCE: Everis
View the original press release on ACCESS Newswire
B.Martinez--TFWP
